e-miRgency will be a company selling medical devices for point-of-care diagnosis. The patented technology based on microfluidics and electrochemistry allows to detect short nucleic acids fast, sensitively and error-free compared to RT-qPCR. This technology is a result of 8 years of academic research and CNRS pre-maturation. The portable device (TRL 5) was built in collaboration between 3 researchers from Centre de Nanosciences et Nanotechnologies in Paris Saclay.
We hope our technology can bring diagnosis to the patients’ bedside avoiding long and costly turn-over times and equipments.
We are looking for a CEO that will take the lead in business aspects of the project including:
We are looking for a person ready to take the leadership of our company and collaborate closely with our CSO and CTO to define the strategy. The candidate must have a background in business and a strong interest in medical device market. A prior experience in biotech would be appreciated.
We offer the possibility of joining, as CEO and cofounder, a project with the potential of strongly impact in the biotech sector, leading the development of the company.